Brief: Cytodyn And FDA Will Meet To Potentially Finalize Protocol For Pivotal Monotherapy Trial For Leronlimab
07/06/2019 11:19
June 7 (Reuters) - Cytodyn Inc CYDY.PK :
* CYTODYN AND FDA WILL MEET TO POTENTIALLY FINALIZE PROTOCOL
FOR
PIVOTAL MONOTHERAPY TRIAL FOR LERONLIMAB
* CYTODYN - DEVELOPING A CLINICAL TRIAL COLLABORATION TO
INITIATE
A HIV PREVENTION STUDY TO BE CONDUCTED BY A PUBLIC HEALTH AGENCY
IN SOUTHEAST ASIA
Source text for Eikon: ID:nGNXkC47p
Further company coverage: CYDY.PK
((Briefs@thomsonreuters.com;))
Recent news on Cytodyn
See all newsBrief: Cytodyn Appoints Robert E. Hoffman As Chief Executive Officer
Brief: Cytodyn Closes $17.5 Million Financing To Fund Continued Development Of Leronlimab
Brief: CytoDyn Inc Files For Offering Of Up To 120 Million Shares Of Common Stock By Selling Stockholder - SEC Filing
Brief: Cytodyn Files For Mixed Shelf Of Up To $100 Million - SEC Filing
Brief: CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer